T5O Share Price Performance
€1.02
-4.10 (-80.02%)
Price €1.02
Share Pricen/a
bioXXmed AG Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
T5O Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
bioXXmed AG Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -3.28
- 100.00%
- -4,347.37%
- 214.3%
About T5O
- Founded
- 2000
- Employees
- 1
- CEO
- WebsiteView website
bioXXmed AG, an investment company, invests in biotechnology or medical technology companies with equity or debt capital. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. bioXXmed AG was founded in 2000 and is based in Heidelberg, Germany.
